Home/Filings/4/0001209191-18-053071
4//SEC Filing

Eichler Kurt M 4

Accession 0001209191-18-053071

CIK 0001566373other

Filed

Oct 1, 8:00 PM ET

Accepted

Oct 2, 4:04 PM ET

Size

7.9 KB

Accession

0001209191-18-053071

Insider Transaction Report

Form 4
Period: 2018-10-01
Transactions
  • Award

    Common Stock

    2018-10-01+978588,075 total
Holdings
  • Common Stock

    (indirect: See footnote)
    1,200
  • Common Stock

    (indirect: See footnote)
    19,791
  • Common Stock

    (indirect: See footnote)
    10,000
Footnotes (4)
  • [F1]Pursuant to the Issuer's Non-Employee Director Compensation Policy, the shares on this Form 4 were automatically issued to the Reporting Person, who previously elected to take shares in lieu of cash compensation for services as a director and committee member of the Issuer.
  • [F2]These shares are directly held by Theresa Eichler as custodian for Katherine Eichler UGMA NJ. Teresa Eichler and Katherine Eichler are immediate family members sharing a household with the Reporting Person.
  • [F3]These shares are directly held by the Kurt M. Eichler Trust Under Agreement dated 12/27/14 FBO Katherine Eichler (the "Katherine Eichler Trust"). The Reporting Person's immediate family member, Katherine Eichler, is a beneficiary of the Katherine Eichler Trust, and the Reporting Person is a trustee of the Katherine Eichler Trust.
  • [F4]These shares are directly held by the Reporting Person as custodian for Katherine Eichler. Katherine Eichler is an immediate family member sharing a household with the Reporting Person.

Issuer

Spring Bank Pharmaceuticals, Inc.

CIK 0001566373

Entity typeother

Related Parties

1
  • filerCIK 0001424591

Filing Metadata

Form type
4
Filed
Oct 1, 8:00 PM ET
Accepted
Oct 2, 4:04 PM ET
Size
7.9 KB